Literature DB >> 1380747

Modulation of in vitro cell growth of human and murine urothelial tumor cell lines under the influence of interleukin-3, granulocyte-, macrophage- and granulocyte-colony-stimulating factor.

T Block1, F Schmid, B Geffken, U Treiber, R Busch, R Hartung.   

Abstract

To elucidate possible growth-modulating effects of interleukin 3 (IL-3), granulocyte-macrophage-colony-stimulating factor (GM-CSF) and granulocyte-colony-stimulating factor (G-CSF), human transitional cell carcinoma (TCC) cell lines T24, RT112, EJ and 647 V were solitarily and continuously exposed to these hematopoietic growth factors at concentrations of 1-100 ng/ml. The murine line MBT-2 was used as a negative and the colon carcinoma cell line HTB38 as a positive control, because of species specificity and known proliferation in response to growth factors, respectively. In the T24 TCC-line solitary and continuous exposure to IL-3, GM-CSF and G-CSF at the highest concentration of 100 ng/ml led to a significant proliferation of cell growth in vitro. Significant proliferation in the RT112 line was only achieved with continuous exposure to IL-3 and GM-CSF (100 ng/ml); G-CSF failed to induce growth modulation in the RT112 line. No significant proliferative effect of any of cytokines administered was observed in the 647V line. Exposure of the EJ line to cytokines at the highest activity levels had a proliferative effect only in suboptimal growth conditions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1380747     DOI: 10.1007/bf00300261

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  10 in total

1.  Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells.

Authors:  W E Berdel; S Danhauser-Riedl; G Steinhauser; E F Winton
Journal:  Blood       Date:  1989-01       Impact factor: 22.113

2.  Regulatory effects of cell density on the binding of transforming growth factor beta, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor.

Authors:  A Rizzino; P Kazakoff; E Ruff; C Kuszynski; J Nebelsick
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701

3.  Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic origin.

Authors:  S Dedhar; L Gaboury; P Galloway; C Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

4.  Interferon gamma and granulocyte/macrophage colony-stimulating factor inhibit growth and induce antigens characteristic of myeloid differentiation in small-cell lung cancer cell lines.

Authors:  M R Ruff; W L Farrar; C B Pert
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

5.  Nonhematopoietic tumor cells express functional GM-CSF receptors.

Authors:  G C Baldwin; J C Gasson; S E Kaufman; S G Quan; R E Williams; B R Avalos; A F Gazdar; D W Golde; J F DiPersio
Journal:  Blood       Date:  1989-03       Impact factor: 22.113

6.  Escalated therapy for refractory urothelial tumors: methotrexate-vinblastine-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-stimulating factor.

Authors:  C J Logothetis; F H Dexeus; A Sella; R J Amato; R G Kilbourn; L Finn; J U Gutterman
Journal:  J Natl Cancer Inst       Date:  1990-04-18       Impact factor: 13.506

7.  Granulocyte-colony stimulating factor enhances the cytotoxic effects of methotrexate to bladder cancer cells in vitro.

Authors:  T Ohigashi
Journal:  Keio J Med       Date:  1990-12

8.  Failure of GM-CSF to influence the growth of small cell and non-small cell lung cancer cell lines in vitro.

Authors:  P R Twentyman; K A Wright
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

9.  Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium.

Authors:  J L Gabrilove; A Jakubowski; H Scher; C Sternberg; G Wong; J Grous; A Yagoda; K Fain; M A Moore; B Clarkson; Herbert F Oettgen; Kirby Alton; Karl Welte; Lawrence Souza
Journal:  N Engl J Med       Date:  1988-06-02       Impact factor: 91.245

10.  Human granulocyte-macrophage colony-stimulating factor modulates in vitro growth in only a minority of continuous human tumour cell lines. EORTC Clonogenic Assay Screening Study Group.

Authors: 
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

  10 in total
  1 in total

1.  Inhibitory effects on in vitro cell growth of human urothelial tumor cell lines under the combined administration of hematopoietic growth factors and clinically relevant antineoplastic agents.

Authors:  T Block; U Treiber; B Geffken; M Vogel; A R Hanauske; F Schmid; R Hartung; R Busch
Journal:  Urol Res       Date:  1993-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.